
<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>World Pharma News / aiglesias / Voted News</title>
<link>http://www.worldpharmanews.net</link>
<description>World Pharma News .net - Web 2.0 pharmaceutical news portal</description>
<pubDate>Thu, 31 Jan 2008 21:02:39 +0200</pubDate>
<language>en</language>
<item>
<title><![CDATA[Bayer Schering Pharma paves the way to the next important oral contraceptive milestone]]></title>
<link>http://www.worldpharmanews.net/Product/Bayer_Schering_Pharma_paves_the_way_to_the_next_important_oral_contraceptive_milestone/</link>
<comments>http://www.worldpharmanews.net/Product/Bayer_Schering_Pharma_paves_the_way_to_the_next_important_oral_contraceptive_milestone/</comments>
<pubDate>Thu, 31 Jan 2008 21:02:39 +0200</pubDate>
<dc:creator>worldpharmanews</dc:creator>
<category>Product</category>
<guid>http://www.worldpharmanews.net/Product/Bayer_Schering_Pharma_paves_the_way_to_the_next_important_oral_contraceptive_milestone/</guid>
<description><![CDATA[Bayer Schering Pharma AG, Germany, has submitted for registration the first combined oral contraceptive product based on estradiol and the progestin dienogest to all Member States of the European Community. The Netherlands will serve as the Reference Member State for the Decentralized Procedure to gain European-wide Marketing Authorization.<br/><br/>1 Vote(s) ]]></description>
</item>

</channel>
</rss>
